J. Buss

发表

Paramagnetic oligonucleotides: contrast agents for magnetic resonance imaging with proton relaxation enhancement effects.

P. Schmalbrock, J. Hines, G. Ammar, 1999, Bioconjugate chemistry.

Original Contribution Iron chelation in the biological activity of curcumin i

E. Pietsch, R. Planalp, F. Torti, 2006 .

Alternative treatment paradigm for thalassemia using iron chelators.

P. Ponka, S. Soe-Lin, M. Trudel, 2008, Experimental hematology.

Ferrous ion strongly promotes the ring opening of the hydrolysis intermediates of the antioxidant cardioprotective agent dexrazoxane (ICRF-187).

B. Hasinoff, J. Buss, 1995, Archives of biochemistry and biophysics.

Lipophilicity of analogs of pyridoxal isonicotinoyl hydrazone (PIH) determines the efflux of iron complexes and toxicity in K562 cells.

P. Ponka, J. Buss, E. Arduini, 2003, Biochemical pharmacology.

Mobilization of intracellular iron by analogs of pyridoxal isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes.

P. Ponka, J. Buss, E. Arduini, 2002, Biochemical pharmacology.

Pyridoxal isonicotinoyl hydrazone and its analogues.

P. Ponka, M. Hermes-Lima, J. Buss, 2002, Advances in experimental medicine and biology.

Hydrolysis of pyridoxal isonicotinoyl hydrazone and its analogs.

P. Ponka, J. Buss, 2003, Biochimica et biophysica acta.

The role of iron chelation in cancer therapy.

F. Torti, S. Torti, J. Buss, 2003, Current medicinal chemistry.

Iron chelators in cancer chemotherapy.

B. Greene, J. Turner, F. Torti, 2004, Current topics in medicinal chemistry.

Iron chelation in the biological activity of curcumin.

R. Planalp, F. Torti, S. Torti, 2006, Free radical biology & medicine.

Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties.

C. Weber, J. Neuzil, P. Ponka, 2003, Biochemical pharmacology.

Oxidative stress mediates toxicity of pyridoxal isonicotinoyl hydrazone analogs.

J. Neuzil, P. Ponka, J. Buss, 2004, Archives of biochemistry and biophysics.

The one-ring open hydrolysis product intermediates of the cardioprotective agent ICRF-187 (dexrazoxane) displace iron from iron-anthracycline complexes

B. Hasinoff, J. Buss, 1993, Agents and Actions.

Metal ion-promoted hydrolysis of the antioxidant cardioprotective agent dexrazoxane (ICRF-187) and its one-ring open hydrolysis products to its metal-chelating active form

B. Hasinoff, J. Buss, 1997 .

The effect of dexrazoxane (ICRF-187) on doxorubicin- and daunorubicin-mediated growth inhibition of Chinese hamster ovary cells.

Y. Ling, B. Hasinoff, J. Yalowich, 1996, Anti-cancer drugs.

Tissue-specific expression of ferritin H regulates cellular iron homoeostasis in vivo.

H. Bujard, K. Schönig, F. Torti, 2006, The Biochemical journal.

Mobilization of iron from cells by hydroxyquinoline-based chelators.

P. Ponka, B. Stranix, J. Buss, 2005, Biochemical pharmacology.

The prolyl 4‐hydroxylase inhibitor ethyl‐3,4‐dihydroxybenzoate generates effective iron deficiency in cultured cells

K. Pantopoulos, P. Ponka, Guohua Chen, 2002, FEBS letters.